SMTL ID : 4cmo.1

Structure of the Human Anaplastic Lymphoma Kinase in Complex with the inhibitor 2-((1R)-1-((3-amino-6-(2-methoxypyridin-3-yl)pyrazin-2-yl) oxy)ethyl)-4-fluoro-N-methylbenzamide

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.05 Å

Oligo State

monomer

Ligands

1 x YPW: 2-[(1R)-1-{[3-amino-6-(2-methoxypyridin-3-yl)pyrazin-2-yl]oxy}ethyl]-4-fluoro-N-methylbenzamide(Non-covalent)

YPW.1: 14 residues within 4Å: Chain A: L.38, V.46, A.64, L.112, E.113, L.114, M.115, A.116, G.118, R.169, N.170, L.172, G.185, D.186 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:V.46, A:L.172 Hydrogen bonds: A:E.113, A:M.115 Halogen bonds: A:N.170

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Johnson, T.W. et al., Discovery of (10R)-7-Amino-12-Fluoro-2,10,16-Trimethyl-15-Oxo-10,15,16,17-Tetrahydro-2H-8,4-(Metheno)Pyrazolo[4,3-H][2,5,11]Benzoxadiazacyclotetradecine-3-Carbonitrile (Pf-06463922), a Macrocyclic Inhibitor of Alk/Ros1 with Pre-Clinical Brain Exposure and Broad Spectrum Potency Against Alk-Resistant Mutations. J.Med.Chem. (2014)

Release Date

2014-05-28

Peptides

ALK TYROSINE KINASE RECEPTOR: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

ALK TYROSINE KINASE RECEPTOR

Related Entries With Identical Sequence